129 related articles for article (PubMed ID: 25449698)
1. Serine protease inhibitors interact with IFN-γ through up-regulation of FasR; a novel therapeutic strategy against cancer.
Shadrin N; Shapira MG; Khalfin B; Uppalapati L; Parola AH; Nathan I
Exp Cell Res; 2015 Jan; 330(2):233-239. PubMed ID: 25449698
[TBL] [Abstract][Full Text] [Related]
2. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
Frydrych I; Mlejnek P
J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
[TBL] [Abstract][Full Text] [Related]
3. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents.
Lotem J; Sachs L
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12507-12. PubMed ID: 8901612
[TBL] [Abstract][Full Text] [Related]
4. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B.
Kim H; Lee HS; Chang KT; Ko TH; Baek KJ; Kwon NS
J Immunol; 1995 May; 154(9):4741-8. PubMed ID: 7536778
[TBL] [Abstract][Full Text] [Related]
5. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) do not inhibit caspase-3 and caspase-7 processing in cells exposed to pro-apoptotic inducing stimuli.
Frydrych I; Mlejnek P
J Cell Biochem; 2008 Dec; 105(6):1501-6. PubMed ID: 18980241
[TBL] [Abstract][Full Text] [Related]
6. Activation of chymotrypsin-like serine protease(s) during apoptosis detected by affinity-labeling of the enzymatic center with fluoresceinated inhibitor.
Grabarek J; Dragan M; Lee BW; Johnson GL; Darzynkiewicz Z
Int J Oncol; 2002 Feb; 20(2):225-33. PubMed ID: 11788882
[TBL] [Abstract][Full Text] [Related]
7. Involvement of TLCK-sensitive serine protease in colchicine-induced cell death of sympathetic neurons in culture.
Mitsui C; Sakai K; Ninomiya T; Koike T
J Neurosci Res; 2001 Nov; 66(4):601-11. PubMed ID: 11746380
[TBL] [Abstract][Full Text] [Related]
8. Can application of serine protease inhibitors TPCK and TLCK provide evidence for possible involvement of serine protease Omi/HtrA2 in imatinib mesylate-induced cell death of BCR-ABL-positive human leukemia cells?
Mlejnek P
Leukemia; 2005 Jun; 19(6):1085-7. PubMed ID: 15800674
[No Abstract] [Full Text] [Related]
9. The serine protease inhibitor TLCK attenuates intrinsic death pathways in neurons upstream of mitochondrial demise.
Reuther C; Ganjam GK; Dolga AM; Culmsee C
Apoptosis; 2014 Nov; 19(11):1545-58. PubMed ID: 25146045
[TBL] [Abstract][Full Text] [Related]
10. Involvement of proteases in the action of IFN-gamma on WISH cells.
Aharon M; Dvilansky A; Shpilberg O; Nathan I
J Interferon Cytokine Res; 2002 Aug; 22(8):847-52. PubMed ID: 12396723
[TBL] [Abstract][Full Text] [Related]
11. The serine protease inhibitors TLCK and TPCK inhibit the in vitro immortalization of primary human keratinocytes by HPV-18 DNA.
Stöppler H; Koval D; Schlegel R
Oncogene; 1996 Oct; 13(7):1545-8. PubMed ID: 8875993
[TBL] [Abstract][Full Text] [Related]
12. Fas aggregation does not correlate with Fas-mediated apoptosis.
Lee Y; Shacter E
J Immunol; 2001 Jul; 167(1):82-9. PubMed ID: 11418635
[TBL] [Abstract][Full Text] [Related]
13. A role for serine proteases in mediating phorbol ester-induced differentiation of HL-60 cells.
Bestilny LJ; Riabowol KT
Exp Cell Res; 2000 Apr; 256(1):264-71. PubMed ID: 10739673
[TBL] [Abstract][Full Text] [Related]
14. The serine protease inhibitors, tosylphenylalanine chloromethyl ketone and tosyllysine chloromethyl ketone, potently inhibit pp70s6k activation.
Grammer TC; Blenis J
J Biol Chem; 1996 Sep; 271(39):23650-2. PubMed ID: 8798584
[TBL] [Abstract][Full Text] [Related]
15. Pro- and anti-apoptotic effects of an inhibitor of chymotrypsin-like serine proteases.
King MA; Halicka HD; Darzynkiewicz Z
Cell Cycle; 2004 Dec; 3(12):1566-71. PubMed ID: 15539954
[TBL] [Abstract][Full Text] [Related]
16. A serine protease inhibitor, N-alpha-tosyl-l-lysine chloromethyl ketone, prolongs rat hepatic allograft survival.
Zhang JL; Yamaguchi Y; Mori K; Okabe K; Hidaka H; Ohshiro H; Uchino S; Ishihara K; Furuhashi T; Yamada S; Ogawa M
J Surg Res; 2001 Apr; 96(2):296-303. PubMed ID: 11266287
[TBL] [Abstract][Full Text] [Related]
17. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
Hughes FM; Evans-Storms RB; Cidlowski JA
Cell Death Differ; 1998 Dec; 5(12):1017-27. PubMed ID: 9894608
[TBL] [Abstract][Full Text] [Related]
18. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
Huang Y; Sheikh MS; Fornace AJ; Holbrook NJ
Oncogene; 1999 Jun; 18(23):3431-9. PubMed ID: 10376521
[TBL] [Abstract][Full Text] [Related]
19. Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death.
Tsushima H; Imaizumi Y; Imanishi D; Fuchigami K; Tomonaga M
Exp Hematol; 1999 Mar; 27(3):433-40. PubMed ID: 10089905
[TBL] [Abstract][Full Text] [Related]
20. Modulation of tryptase and histamine release from human lung mast cells by protease inhibitors.
He S; Xie H
Asian Pac J Allergy Immunol; 2004 Dec; 22(4):205-12. PubMed ID: 15783133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
